JP2000290184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000290184A5 JP2000290184A5 JP1999095033A JP9503399A JP2000290184A5 JP 2000290184 A5 JP2000290184 A5 JP 2000290184A5 JP 1999095033 A JP1999095033 A JP 1999095033A JP 9503399 A JP9503399 A JP 9503399A JP 2000290184 A5 JP2000290184 A5 JP 2000290184A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- unsubstituted
- represented
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
（式中、Ｒ１及びＲ２は、同一または異なって、水素、ヒドロキシルメチル基、メルカプトメチル基、置換もしくは非置換のアルコキシメチル基、置換もしくは非置換のアルキルチオメチル基、置換もしくは非置換のアルケニルオキシメチル基、または置換もしくは非置換のアルケニルチオメチル基を表し、Ｒ３は、アルキル基を表す）で表される化合物（Ｋ２５２ａ誘導体）［以下、一般式（Ｉ）で表される化合物を化合物（Ｉ）という。他の式番号の化合物についても同様である］は、アルツハイマー病などの神経変性疾患の治療に有益な化合物である［Ｊ．Ｍｅｄ．Ｃｈｅｍ．，４０，１８６３−１８６９（１９９７）、特表平６−５０４７３１、ＷＯ９６／１３５０６］。
(Wherein, R 1 and R 2 are the same or different and each represents hydrogen, hydroxylmethyl group, mercaptomethyl group, substituted or unsubstituted alkoxymethyl group, substituted or unsubstituted alkylthiomethyl group, substituted or unsubstituted alkenyl A compound (K252a derivative) represented by an oxymethyl group or a substituted or unsubstituted alkenylthiomethyl group, and R 3 represents an alkyl group [hereinafter, a compound represented by the general formula (I) (I). The same applies to compounds of other formula numbers] are compounds useful for treating neurodegenerative diseases such as Alzheimer's disease [J. Med. Chem. , 40 , 1863-1869 (1997), JP-T-6-504731, WO96 / 13506].
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11095033A JP2000290184A (en) | 1999-04-01 | 1999-04-01 | Nasal formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11095033A JP2000290184A (en) | 1999-04-01 | 1999-04-01 | Nasal formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000290184A JP2000290184A (en) | 2000-10-17 |
| JP2000290184A5 true JP2000290184A5 (en) | 2006-05-18 |
Family
ID=14126786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11095033A Pending JP2000290184A (en) | 1999-04-01 | 1999-04-01 | Nasal formulation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000290184A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3752123T2 (en) * | 1987-03-09 | 1998-05-14 | Kyowa Hakko Kogyo Kk | DERIVATIVES OF THE PHYSIOLOGICALLY ACTIVE AGENT K-252 |
| GB8712176D0 (en) * | 1987-05-22 | 1987-06-24 | Cosmas Damian Ltd | Drug delivery system |
| JPH07242550A (en) * | 1994-03-02 | 1995-09-19 | Teijin Ltd | Secondary hyperparathyroidism treatment |
| PT912184E (en) * | 1996-06-25 | 2002-12-31 | Cephalon Inc | USE OF A K-252A DERIVATIVE FOR THE TREATMENT OF CENTRAL OR PERIPHERAL NERVOUS SIETMA DISEASES AND CITOQUINE OVER-PRODUCTION |
-
1999
- 1999-04-01 JP JP11095033A patent/JP2000290184A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002016357A3 (en) | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) | |
| BR0000968A (en) | oxamic acids containing cyano and its derivatives as ligands for thyroid receptors | |
| WO2005095384A8 (en) | Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists | |
| JP2004500426A5 (en) | ||
| BRPI0416216A (en) | glycoimidazole and polyhydroxycyclohexenyl compound and method for synthesizing glycoimidazole and polyhydroxycyclohexenyl compound, methods for inhibiting glucocerebrosidase, for enhancing glucocerebrosidase activity, pharmaceutical composition, methods for inhibiting a -glycosity, and for treating gaucher disease, glycoimidazole and polyhydroxycyclohexylamine derivatives | |
| PT1063228E (en) | DERIVATIVES OF CICLOALCENOS PROCESS FOR THEIR PREPARATION AND USE | |
| JP2002527414A5 (en) | ||
| DK1018511T3 (en) | Isochroman compounds and processes for their preparation | |
| ATE268751T1 (en) | BIPHENYLAMIDINE DERIVATIVES | |
| BR0311338A (en) | N-Acylaminobenzene derivatives as selective inhibitors of monoamine oxicity b | |
| NO932520D0 (en) | PREPARATION FOR HEALING THE DISEASE SJOEGREN'S SYNDROME | |
| DE69834500D1 (en) | XANTHINE DERIVATIVES FOR THE TREATMENT OF BRAINISHEMIA | |
| ATE316089T1 (en) | ISOINDOLE DERIVATIVES | |
| NO942309L (en) | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivatives | |
| WO2002036118A3 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
| JP2000290184A5 (en) | ||
| ATE284684T1 (en) | AMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OF THE RETINA | |
| CY1110622T1 (en) | NEW PRODUCTS OF 3-PHENYLOPROPIONIC ACID FOR TREATMENT OF DIABETES | |
| ATE165822T1 (en) | CHINOLINE-4-CARBONYLGUANIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| AR019197A1 (en) | COMPOSITES DERIVED FROM PIPERIDINE ANTIHISTAMINICS, INTERMEDIATE COMPOUNDS, PROCEDURE FOR PREPARATION OF PIPERIDINE DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF INTERMEDIARIES. | |
| DK0556813T3 (en) | Amphoteric tricyclic compounds such as antihistamine and antiallergic agents | |
| TW200635911A (en) | Sulfanyl substituted phenyl methanones | |
| EP1493441A4 (en) | THERAPEUTIC AGENT TREATING STOMACH DISORDERS OF FOOD COMPETENCE | |
| WO2007054969A3 (en) | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride | |
| JP2003012516A5 (en) |